Potential new targets in arthritis therapy: interleukin (IL)‐17 and its relation to tumour necrosis factor and IL‐1 in experimental arthritis

類似資料

• Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1
  著者:: Koenders, MI, 等
  出版事項: (2005)
• Role of tumour necrosis factor α in experimental arthritis: separate activity of interleukin 1β in chronicity and cartilage destruction
  著者:: van den Berg, W. B, 等
  出版事項: (1999)
• IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
  著者:: Koenders, MI, 等
  出版事項: (2004)
• Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1
  著者:: Koenders, Marije I., 等
  出版事項: (2005)
• The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models
  著者:: Lubberts, Erik, 等
  出版事項: (2005)